Covington Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$15K Hold
119
﹤0.01% 755
2022
Q2
$16K Buy
119
+19
+19% +$2.59K ﹤0.01% 740
2022
Q1
$14K Hold
100
﹤0.01% 775
2021
Q4
$17K Hold
100
﹤0.01% 709
2021
Q3
$15K Hold
100
﹤0.01% 751
2021
Q2
$13K Hold
100
﹤0.01% 731
2021
Q1
$13K Hold
100
﹤0.01% 661
2020
Q4
$12K Hold
100
﹤0.01% 654
2020
Q3
$11K Hold
100
﹤0.01% 620
2020
Q2
$11K Sell
100
-102
-50% -$10.8K ﹤0.01% 622
2020
Q1
$16K Hold
202
﹤0.01% 553
2019
Q4
$22K Hold
202
﹤0.01% 582
2019
Q3
$22K Buy
202
+102
+102% +$10.5K ﹤0.01% 543
2019
Q2
$10K Hold
100
﹤0.01% 639
2019
Q1
$9K Hold
100
﹤0.01% 619
2018
Q4
$8K Hold
100
﹤0.01% 653
2018
Q3
$11K Hold
100
﹤0.01% 591
2018
Q2
$11K Hold
100
﹤0.01% 612
2018
Q1
$10K Hold
100
﹤0.01% 635
2017
Q4
$10K Hold
100
﹤0.01% 670
2017
Q3
$9K Buy
+100
New +$10.6K ﹤0.01% 621
2016
Q3
Sell
-3,650
Closed -$297K 229
2016
Q2
$297K Buy
3,650
+95
+3% +$7.23K 0.03% 206
2016
Q1
$254K Buy
3,555
+105
+3% +$7.04K 0.02% 212
2015
Q4
$245K Hold
3,450
0.02% 219
2015
Q3
$212K Hold
3,450
0.02% 228
2015
Q2
$250K Hold
3,450
0.02% 232
2015
Q1
$265K Hold
3,450
0.03% 211
2014
Q4
$231K Buy
+3,450
New +$218K 0.02% 248

Other funds holding DGX

Covington Capital Management's DGX Position: Q3 2022 in Review

Covington Capital Management held its Quest Diagnostics (DGX) position steady in Q3 2022 at 119 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #755.

Covington Capital Management first reported a position in DGX in Q4 2014 and has held it in 28 quarters since. The position peaked at $297K in Q2 2016. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.

  • Covington Capital Management held 119 shares of Quest Diagnostics worth $15K as of Q3 2022.
  • Covington Capital Management left its Quest Diagnostics share count unchanged in Q3 2022.
  • Quest Diagnostics made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #755 holding.
  • Covington Capital Management first reported a position in Quest Diagnostics in Q4 2014 and has held it in 28 quarters since.
  • Covington Capital Management's Quest Diagnostics position peaked at $297K in Q2 2016.
  • 809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.